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ABSTRACT

The parasitic protist Trypanosoma cruzi is the causative agent of Chagas
Disease. Chagas Disease causes greater than 15,000 deaths each year, and nearly 28
million people are believed to be at risk of infection in Central and South America.
This parasite has been described in many mammalian host species and has also
been described in the United States. The purpose of this study was to attempt to use
PCR to amplify T. cruzi-specific DNA directly from blood samples obtained from
raccoons (Procyon lotor) trapped in Warren and Barren Counties of Kentucky in
2007 and 2008. DNA was successfully isolated from 487raccoon blood samples
using a Qiagen QIAmp DNA Blood Mini Kit. Each DNA sample was then subjected to
PCR amplification using the T. cruzi specific primer pair known as TCZ1 and TCZ2. It
was determined that T. cruzi DNA was present in 47% of raccoon blood samples
with a 57% prevalence in Warren county and a 32% prevalence in Barren county.
Groce (2008) estimated a similar overall prevalence of 38% in these same raccoons
based upon the results of hemocultures established at the time of sample collection.

Keywords: Trypanosoma cruzi, Chagas Disease, PCR, TCZ1, TCZ2, Gel
Electrophoresis.
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CHAPTER ONE
INTRODUCTION
Discovery of Chagas Disease:
While studying malaria in Brazil in 1909, Carlos Chagas was the first to discover
the protozoan parasite, Trypanosoma cruzi (Chagas, 1909). Chagas noticed
symptoms in the local Brazilian population that he could not attribute to malaria or
to any other known disease. In his life, Chagas was able to determine not only the
clinical symptoms of acute infection, but also the epidemiology and life cycle of the
parasite within the vector and human host (Clayton, 2010 [A]). In honor of Carlos
Chagas’ extensive work, the disease is now known as Chagas Disease.
Chagas by the Numbers:
Chagas disease has taken the lives of countless people due to heart failure
and other cardiological and digestive system maladies. The latest studies estimate
that the disease causes approximately 12,500 to >15,000 deaths each year (Dias et
al., 2008; Clayton, 2010 [A]). In addition, approximately 10-12 million people are
living today who are infected with T. cruzi (Clayton, 2010 [A]), many of whom have
no idea they carry the parasite. Studies have also shown that an estimated 28
million people are at risk of contracting the disease from the insect vectors, bloodsucking bugs in the family Reduviidae (Kirchhoff, 2003). In rural areas, these
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triatome insects (commonly known as “kissing bugs”) reside in the cracks and
crevices of palm trees, wood and rock piles, mud houses and livestock stables.
The acute stage of infection with T. cruzi presents with very general
symptoms: headache, fever, swollen lymph nodes (lymphadenopathy), enlargement
of the liver and spleen (hepatosplenomegaly), and inflammation of cardiac tissue
(myocarditis; CDC DPDx, 2011). One telling clinical sign that can occur is known as a
chagoma. A chagoma is a localized swelling at the site where the parasites enter the
body, and the swelling can last for several weeks before finally subsiding (Rassi et
al. 2010). When this chagoma is localized around the soft mucosa of the orbital
region, it is referred to as Romaña’s sign. Romaña’s sign is the painless unilateral
swelling of the periorbital area that occurs roughly 1 to 2 weeks after exposure
(CDC DPDx, 2011). However, the acute phase of Chagas disease is not always
clinically apparent, and in some cases, acute symptoms don’t even surface at all. The
disease can progress to an asymptomatic (or latent) phase for 30+ years before it
presents again in the chronic phase with cardiac abnormalities, megaesophagus or
megacolon, and ends most notably in congestive heart failure and death (Coura and
Vinas, 2010). Approximately 1/3 of patients who become infected with T. cruzi in
endemic areas eventually develop the chronic manifestations of Chagas disease.
Life cycle of T. cruzi:
Triatome insects in the family Reduviidae are attracted to the CO2 exhaled by
vertebrates, and the bugs take blood meals by biting near the mouth and nose of the
host, usually while the host sleeps (Harder, 2004). As it takes a blood meal, the
2

triatome bug often times defecates. Metacyclic trypomastigote stages of T. cruzi are
present in the bug’s feces, and it is this stage that is infective for the vertebrate host
(CDC DPDx, 2011). The parasites enter broken skin (often at the site of the bite) or
cross the soft mucosal tissues of the eyes, nose and lips (De Souza, 2002). Once inside
the host, the trypomastigotes can enter into most types of tissue (Coura and Viñas,
2010; Clayton, 2010). After entering a host cell, parasites transform into the
amastigote life stage and begin multiplying rapidly by binary fission (CDC 2011, CDC
DPDx 2011). The amastigote stages reside within the cytoplasm of the host cell until
transforming back into trypomastigote stages, or until the host cell dies and bursts
expelling the multitude of amastigotes contained inside. This cycle continues in
many different tissues throughout the body, and can do so for many days before the
host experiences clinically apparent symptoms (Coura and Viñas, 2010).
The life cycle of the parasite continues when the host is again bitten by a
“kissing bug”. The bug ingests infected blood of the host animal or human, and
within the midgut of the triatome insect, trypomastigote stages transform into
epimastigote stages and reproduce asexually to form more metacyclic
trypomastigotes. These stages then migrate to the hindgut of the insect and wait for
defecation to occur. Once the triatome insect takes another blood meal, it defecates
and the cycle begins anew (CDC DPDx, 2011). In addition, oral infection can occur by
consumption of food or beverages contaminated with feces from infected triatome
bugs. Recently, a total of 103 cases of Chagas disease were diagnosed in
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Fig. 1- Summary of life cycle of Trypanosoma cruzi (CDC DPDx, 2011)
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a school in Venezuela when children accidentally ingested contaminated guava juice
(Clayton, 2010 [A]).
In endemic areas of Central and South America, the risk of infection from
blood donations, blood transfusions, and organ donations is also high. In 1960,
patients receiving infected blood transfusions and organ donations in Brazil’s two
largest cities acquired an estimated 16,000 cases of Chagas disease. The World
Health Organization also estimated that roughly 7 million cases of Chagas were
transmitted from infected blood and organs in the entire Latin American region in
that same year (Coura and Viñas, 2010). Although screening and public awareness
have improved significantly in many Latin American countries, the risk of
transfusion and organ donation acquired infection remains unacceptably high in the
region (Clayton, 2010 [B]; Coura and Viñas, 2010). People from Latin America who
carry the disease frequently immigrate to foreign countries potentially unaware of
the infection they carry. This has vast international implications for many
governments and health care systems that have never before experienced or known
about this parasite. Couras and Viñas (2010) recently reported that there are
>300,000 individuals infected with T. cruzi in the United States, >5,500 in Canada,
>80,000 in Europe and in the western Pacific region, >3,000 in Japan and >1,500 in
Australia. With the world rapidly moving towards globalization, this raises the need
for more education and screening for this parasitic infection worldwide.
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Sylvatic cycle of T. cruzi in North America
Within the United States, the sylvatic cycle of infection with T. cruzi has been
described and documented in the states of Alabama, California, Florida, Georgia,
Louisiana, Maryland, Oklahoma, North Carolina, South Carolina, Tennessee, Texas,
Virginia and Kentucky (McKeever et al., 1958; Olsen et al., 1964; John and Hoppe,
1986; Karsten et al., 1992; Yabsley & Noblet, 2002; Dorn et al, 2007; Hancock et al,
2005; Groce, 2008). The most recent study, conducted by Groce in 2008, reported a
high prevalence of infection with T. cruzi in raccoons and opossums trapped in
Warren and Barren Counties of south central Kentucky. Within the North American
continent, T. cruzi has been identified in many mammalian hosts including raccoons
(Procyon lotor), opossums (Didelphis virginiana), gray foxes (Urocyon
cineroargenteus), striped skunks (Mephitis mephitis), macaques (Macaca silenus),
lemurs (Lemur catta), woodrats (Neatoma magister), armadillos (Dasypus
novemcincthus), bats (Eptiscus fuscus), moles (Neurotrichus gibbsii), and dogs (Canis
familiaris) (Yabsley et al., 2001; James et al., 2002; Hall et al., 2007). Despite
infecting a wide variety of mammalian hosts in North America, the incidence of
human infection remains low, with only seven confirmed autochthonous cases
occurring within the United States (Bern et al., 2007). The rate of infection within the
United States is so low presumably due to better living conditions and different feeding
habits of the Triatome vector.
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Detection of T. cruzi:
There have been several different methods employed to detect T. cruzi in
samples of blood, including direct microscopy, xenodiagnosis, hemoculture, and
polymerase chain reaction (PCR). The PCR method utilizes gene specific
oligonucleotide primers that target a distinct gene sequence within a sample, and
amplifies that gene sequence potentially hundreds of thousands of time. These
thousands of copies of the DNA sequence (known as amplicons or PCR products)
can then be visualized following agarose gel electrophoresis to determine the
presence/absence of the target sequence within the sample. Studies have proven
that PCR is far more sensitive than microscopic methods (Kirchhoff et al., 1996),
especially when using the TCZ1 and TCZ2 primer pair (Moser et al., 1989). The
TCZ1 and TCZ2 primers are specific for a highly conserved 195-base pair (bp)
repetitive nuclear sequence of T. cruzi (Moser et al., 1989). The goal of the present
study was to attempt to use PCR to amplify T. cruzi-specific DNA directly from blood
samples obtained from raccoons (Procyon lotor) trapped in Warren and Barren
Counties of Kentucky in 2007 and 2008. We hypothesize that PCR analysis will
allow for a more accurate determination of the prevalence of T. cruzi infection in
raccoons than the hemoculture method previously employed by Groce in 2008.
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CHAPTER 2
MATERIALS AND METHODS
DNA Extraction:
200 μL of whole, non-coagulated blood samples stored at 4oC from 47 raccoon
specimens were used in this study. DNA was extracted using the Qiagen QIAamp®
DNA blood mini kit, according to the manufacturer’s recommended protocol.
Afterwards, DNA concentration was determined using a Thermo Nanodrop ND-100
spectrophotometer. Purified DNA samples were stored at -20oC until use.
PCR Amplification:
PCR amplification was performed on each DNA sample, using the TCZ1 and TCZ2
primer set. The TCZ1 and TCZ2 primer pair was designed to amplify 188 bp of a
195-bp repetitive nuclear sequence of T. cruzi (Moser et al., 1989). The TCZ1 and
TCZ2 primers consisted of the following nucleotide sequences: TCZ1 (5’-CGA GCT
CTT GCC CAC ACG GGT GCT 3’) TCZ2 (5’-CCT CCA AGC AGC GGA TAG TTC
AGG 3’). For each PCR analysis, a 50µl reaction was set up containing 20µl 2.5X
Master Mix (5 Prime, Gaithersburg, MD), 1 µl (4µM) of each primer, a standardized
amount of template DNA, and sterile nanopure water to bring the total volume to 50
µl. A negative control containing sterile nanopure water in place of template DNA
was included with each analysis. Two positive controls using template DNA

8

prepared from T. cruzi type I and type IIa reference strains were also included.
Reaction mixtures were loaded into an automated DNA thermal cycler to undergo
amplification according to the protocol outlined in Table 1. The TCZ1 and TCZ2
primers are highly specific for T. cruzi-DNA, and should not amplify other DNA that
is found within the blood samples (i.e. raccoon leukocyte DNA).

Table 1. Thermocycler Protocol used for TCZ1 and TCZ2 primers.
Steps
Initial Denature
Denature
Annealing
Extension
Final extension
Hold

Temperature (°C)
94
94
64.5
72
72
4

Time
2 min
1 min
30 sec
15 sec
5 min
Indefinite

# of cycles
1
30

1
1

Agarose Gel Electrophoresis:
Once all of the samples had been subjected to the PCR procedure, a 2 μL
sample of the resulting PCR products were stained with a phosphorescent dye and
loaded onto 3% agarose gels and subjected to electrophoresis at 80V for 2 hours to
separate the amplified DNA fragments. The resulting gels were imaged using a
Fluorochem HD2 ultraviolet imager. A 50bp DNA ladder was employed to allow an
estimate of the length of our target DNA sequence. Additionally, the PCR procedure
was repeated on all samples, to confirm results.
9

After gels were analyzed and the positive and negative samples were
determined, results were compared to the 2008 study performed by Groce, to
determine how PCR analysis performed in comparison to hemoculture.
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CHAPTER 3
RESULTS
After total DNA was isolated from each blood sample using the Qiagen QIAamp®
DNA blood mini kit, DNA concentrations were measured using a Nanodrop ND-1000
spectrophotometer. Concentrations ranged from 8.6 ng/μL to 210.9 ng/μL, with an
average concentration of between 30 and 50 ng/μL. These values are shown in
Tables 1 and 2 below.
Following PCR amplification of all DNA samples, products were analyzed by
agarose gel electrophoresis. Twenty-two out of 47 DNA samples were judged to be
PCR positive for T. cruzi DNA based on the presence of a 188 bp band visible in the
gel with UV illumination. The results of PCR analysis on Warren County raccoon
DNA samples are shown in Figures 2a and 2b and the results of PCR analysis on
Barren County raccoon DNA samples are shown in Figure 3. Results are also
summarized in Tables 2 and 3.
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200 BP

Figure 2A. PCR products resulting from amplification of raccoon DNA (RW series; part
I) with primers TCZ1 and TCZ2 followed by agarose gel electrophoresis (3% gel).

Figure 2B. PCR products resulting from amplification of raccoon DNA (RW series; part
II) with primers TCZ1 and TCZ2 followed by agarose gel electrophoresis (3% gel).
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Figure 3. PCR products resulting from amplification of raccoon DNA (RB series) with
primers TCZ1 and TCZ2 followed by agarose gel electrophoresis (3% gel)

Gel electrophoresis was repeated on the samples that were faintly positive or
samples that were judged to be positive by hemoculture or by prior PCR analysis.
The results of this second electrophoretic analysis can be seen in Figure 4.
Hemoculture results versus PCR positi
positive
ve samples are shown in Tables 4 and 5.
5 In all,
there were 7 additional positive samples in which the sample was PCR positive and
hemoculture negative in our data, and 3 discrepancies where the hemoculture
showed positive results and the PCR negative.
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Tables 2 and 3: Sample number, concentration, and presence of T. cruzi DNA
for Warren and Barren counties, respectively.
Sample Number
(Warren Series)

DNA Concentration
(ng/μL)

Presence of T.
cruzi DNA?

RW1
RW2
RW3
RW4
RW5
RW6
RW7
RW8
RW9
RW10
RW11
RW12
RW13
RW14
RW15
RW16
RW17
RW18
RW19
RW20
RW21
RW22
RW23
RW24
RW26
RW27
RW28
RW29

67.4
33.3
17.5
34.6
53.9
36.5
31.2
33.6
12.9
35.5
78.7
8.6
155.3
110.7
29.3
32.7
30.3
28.2
32.4
33.6
42.7
36.7
28.7
28.7
77.7
45.1
38.2
48.4

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-
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Sample Number
(Barren Series)

DNA Concentration
(ng/μL)

Presence of T.
cruzi DNA?

RB1
RB2
RB3
RB8
RB9
RB10
RB11
RB12
RB13
RB14
RB15
RB16
RB17
RB18
RB19
RB20
RB21
RB22
RB23

21.0
14.4
10.0
12.0
44.3
45.4
32.6
17.5
210.9
32.7
14.7
21.3
35.3
46.1
40.8
38.4
42.4
31.4
66.5

+
+
+
+
+
+
-

Figure 4. PCR products resulting from amplification of selected raccoon DNA samples
from the RW and RB series with primers TCZ1 and TCZ2 followed by agarose gel
electrophoresis (3% gel).
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Tables 4 and 5: The 2008 Hemoculture versus present PCR data for the Warren and
Barren county samples, respectively. Note: The light gray shading denotes a
negative (-) hemoculture result and a positive (+) PCR result. The dark gray shading
denotes a positive (+) hemoculture result and a negative (-) PCR result.

Sample
RW1
RW2
RW3
RW4
RW5
RW6
RW7
RW8
RW9
RW10
RW11
RW12
RW13
RW14
RW15
RW16
RW17
RW18
RW19
RW20
RW21
RW22
RW23
RW24
RW26
RW27
RW28
RW29

Hemoculture
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-

PCR
Results
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-

Sample
RB1
RB2
RB3
RB8
RB9
RB10
RB11
RB12
RB13
RB14
RB15
RB16
RB17
RB18
RB19
RB20
RB21
RB22
RB23
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Hemoculture
+
+
+
-

PCR
results
+
+
+
+
+
+
-

CHAPTER 4
DISCUSSION
The results of the present study confirm a high prevalence of T. cruzi
infection in raccoon populations in Warren and Barren counties of Kentucky. Direct
PCR amplification of raccoon blood samples using the highly sensitive T. cruzispecific primers TCZ1 and TCZ2 revealed that 57% (16/28) of Warren county
raccoons were positive for T. cruzi DNA and 32% (6/19) of raccoon blood samples
from Barren County were positive. A total of 22 out of 47 raccoons in this study
were judged to contain T. cruzi DNA, giving an overall prevalence of 47% for the
region.
A variety of studies have been performed to determine the prevalence of T.
cruzi in raccoon populations in various regions of the United States over the past
several decades. The prevalence of infection reported in these studies ranged from a
low of 1.5% reported by Mckeever and coworkers in Georgia and Florida in 1958
(Mckeever et al., 1958) to a high of 63% reported in a study performed by John and
Hoppe in Oklahoma in 1986. However, the John and Hoppe study did have a very
small sample size with only 8 raccoon samples collected (John and Hoppe, 1986).
Since many of these studies have been performed, the scientific community has seen
the advent of newer and more sensitive diagnostic methods such as hemoculture,
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indirect immunofluorescence assay (IFAT), enzyme-linked immunosorbent assay
(ELISA) and PCR which have made testing for the parasite much more efficient and
sensitive than the archaic methods of direct visual microscopy and xenodiagnosis.
Every method of parasite detection that has been developed has its
advantages and disadvantages, yet PCR is widely viewed as one of the most sensitive
and effective procedures currently available. Visual microscopy of blood smears or
tissue mounts is the most direct method of identification, however, microscopy has
its disadvantages because the blood or tissues biopsied may not contain the
parasites, the blood and tissues must be fresh in order to preserve the parasite for
identification, and this method is time consuming and does not allow for as many
samples to be processed daily. In contrast, PCR can amplify incredibly small
amounts of DNA within a sample, it can be performed on an older sample (as
demonstrated by this study), and large numbers of samples can be analyzed
simultaneously. PCR also has been shown to be significantly more effective at T.
cruzi identification than direct microscopy (Pizarro et al. 2007). The technique
known as xenodiagnosis is a longstanding indirect method of detecting T. cruzi,
however xenodiagnosis can also fail since the triatome insects do not always ingest
the parasite, and the parasite may not always proliferate within the gut as expected.
This technique also requires the labor-intensive maintenance of large quantities of
triatome bugs in the laboratory. Hemoculture requires blood samples to be
introduced into culture medium under sterile conditions, with hopes that the
parasite will eventually grow and be identified. However, as with other methods,
18

the samples must be fresh and free of bacterial contamination, and the parasites
may not grow as expected. Finally, IFAT is also an effective method of diagnosis, but
it too can be inaccurate because it relies on the immunological response of the host
(raccoon, human). The IFAT can give a false negative result if for some reason the
host is immunologically compromised or if the blood sample is taken too early in the
infection process. The PCR technique is much more effective because it tests
directly for the presence of the parasitic DNA within the sample. It also doesn’t
depend upon the immune response of the host (as with IFAT), or the time
consuming process of in vitro cultivation under sterile conditions (hemoculture).
The PCR technique does depend upon the effectiveness of the chosen primers and
the quality of the DNA samples, but if these conditions are met, PCR can be
extremely specific and sensitive.
The TCZ1 and TCZ2 primers used in this study were carefully chosen for
those exact reasons. The TCZ primer pair recognizes a highly repetitive, non-coding,
nuclear sequence within the T. cruzi genome (Moser et al., 1989; Kirchhoff et al.,
1996). Due to the highly repetitive nature of this sequence within the genome,
amplification occurs at a much higher rate than if the primers were recognizing just
one region of DNA. The TCZ1 and TCZ2 primers are also highly specific and can only
recognize the target DNA sequence and not any other DNA present in the sample.
The selection of the TCZ1 and TCZ2 primers for this study was based upon a careful
review of the literature. Many other studies have shown these primers to be
effective in various situations including identification in insect vectors and reservoir
19

hosts (McKeever et al., 1958; Olsen et al., 1964; John and Hoppe, 1986; Karsten et al.,
1992; Yabsley & Noblet, 2002; Dorn et al, 2007; Hancock et al, 2005; Groce, 2008,
Yabsley et al, 2001; Hall et al, 2007) and in patients with Chagas disease (Avila et al.,
1993; Dorn et al., 2007; Bern et al., 2007;G. Russomando, et al. 1992; G. Russomando
et al. 1998; Leiby, et al. 2000; Maldonado et al., 2004; Carriazo et al., 1998; Marcon
et al., 2011). There have also been studies performed on very old or archived
specimens where it was shown that PCR was still effective in detecting T. cruzi long
after any other method would have been unusable (James et al., 2002; Williams et
al., 2009). For example, TCZ1 and TCZ2 primers were used in a 7 years postmortem patient to determine the exact cause of death by Chagas disease (Ochs et al.,
1996). Studies designed to compare the TCZ 1 and 2 primers with other primer sets
have shown that the TCZ series is by far the most sensitive. In a 2005 study, Virreria
and co-workers tested the TCZ1/TCZ2 primers against nuclear DNA primers
BP1/BP2, O1/O2, Pon1/Pon2, and Tca1/Tca2 and kinetoplast DNA primers
S35'/S36' and 121/122 and showed that TCZ1/TCZ2 primers were the most
sensitive (Virreria et al., 2005). A study in 2006 by Trejo tested the TCZ series

against the kinetoplast DNA primers S35'/S36' and 121/122 and reported the same
findings (Trejo, 2006).
When the PCR results obtained in the present study were compared to the
hemoculture results obtained by Groce in 2008, several discrepancies were
observed. As seen in Tables 4 and 5, there were 7 samples that were originally
hemoculture negative, but were determined to be PCR positive in this study (RW1,
20

RW16, RW23, RW28, RB8, RB19, and RB22). In addition, there were 3 samples that
were hemoculture positive and PCR negative in the present study (RW9, RW18,
RW21). In the cases where this study showed the RW1, RW16, RW23, RW28, RB8,
RB19, and RB22 blood samples to be T. cruzi positive, we can assume that PCR was
the more sensitive of the two methods in detecting the presence of the parasite.
However, in three cases (RW9, RW18, and RW21) it would appear that hemoculture
was more sensitive than PCR. One factor to consider when interpreting these results
is the age of the blood samples at the time of DNA isolation. When this study first
began in 2009, the raccoon blood samples had been stored at 4°C for over a year.
Many investigators have confirmed that PCR can still be effective even years after
samples would be considered to be non viable (James et al., 2002; Williams et al.,
2009; Ochs et al., 1996). However, it seems reasonable to predict that the integrity
of the DNA present in the raccoon blood samples would decrease with extended
storage at 4oC. The only way this could have been avoided would have been to
isolate DNA from the blood samples very soon after the raccoons had been trapped.
What can be understood is that in the case of future studies for T. cruzi prevalence,
multiple detection methods should be employed to get the most accurate results.
In conclusion, PCR has confirmed a high prevalence of T. cruzi infection in the
raccoon populations of Warren and Barren counties in south central Kentucky. Our
results demonstrate that PCR with the TCZ1 and TCZ2 primer pair can be a very
effective method for detecting T. cruzi DNA in raccoon blood samples even after
long-term storage at 4oC. However, to achieve the most accurate estimate of
21

parasite prevalence in wild mammal populations it is recommended that
investigators use a combination of both hemoculture and PCR analysis.
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